UB Paderborn / Katalog / Suche / in CDI

On Connective Tissue Mast Cells as Protectors of Life, Reproduction, and Progeny

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4499

Norrby, Klas

2024

Volltextzugriff (PDF)

Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2014-07, Vol.122 (7), p.565-579

Norrby, Klas

2014

Volltextzugriff (PDF)

Low-molecular-weight heparins and angiogenesis

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2006-02, Vol.114 (2), p.79-102

NORRBY, KLAS

2006

Volltextzugriff (PDF)

Mast cells and angiogenesis

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2002-05, Vol.110 (5), p.355-371

Norrby, Klas

2002

Volltextzugriff (PDF)

Do mast cells contribute to the continued survival of vertebrates?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2022-10, Vol.130 (10), p.618-624

Norrby, Klas

2022

Volltextzugriff (PDF)

Rat mesentery angiogenesis assay

Journal of visualized experiments, 2011-06 (52)

Norrby, Klas C

2011

Volltextzugriff (PDF)

Mast cells and angiogenesis: Review article

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2002-05, Vol.110 (5), p.355-371

NORRBY, Klas

2002

Volltextzugriff (PDF)

Human Apo-Lactoferrin Enhances Angiogenesis Mediated by Vascular Endothelial Growth Factor A in vivo

Journal of vascular research, 2004-01, Vol.41 (4), p.293-304

Norrby, Klas

2004

Volltextzugriff (PDF)

In vivo models of angiogenesis

Journal of cellular and molecular medicine, 2006-07, Vol.10 (3), p.588-612

Norrby, K.

2006

Volltextzugriff (PDF)

Orally administered bovine lactoferrin systemically inhibits VEGF165-mediated angiogenesis in the rat

International journal of cancer, 2001-01, Vol.91 (2), p.236-240

2001

Volltextzugriff (PDF)

Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-12, Vol.118 (12), p.949-957

2010

Volltextzugriff (PDF)

Basic Fibroblast Growth Factor and de Novo Maremarian Angiogenesis

Microvascular research, 1994-07, Vol.48 (1), p.96-113

Norrby, Klas

1994

Volltextzugriff (PDF)

Microvascular Density in Terms of Number and Length of Microvessel Segments per Unit Tissue Volume in Mammalian Angiogenesis

Microvascular research, 1998-01, Vol.55 (1), p.43-53

Norrby, Klas

1998

Volltextzugriff (PDF)

Drug testing with angiogenesis models

Expert opinion on drug discovery, 2008-05, Vol.3 (5), p.533-549

Norrby, Klas

2008

Volltextzugriff (PDF)

Rat Mesentery Angiogenesis Assay

Journal of visualized experiments, 2011-06 (52)

Norrby, Klas C.

2011

Volltextzugriff (PDF)

In vivo angiogenesis models

Journal of cellular and molecular medicine, 2006, Vol.10 (3), p.588

Norrby, Klas

2006

Volltextzugriff (PDF)

2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis

International journal of experimental pathology, 2000-06, Vol.81 (3), p.191-198

Norrby, Klas

2000

Volltextzugriff (PDF)

Drug testing with angiogenesis models

Expert opinion on drug discovery, 2008, Vol.3 (5), p.533

Norrby, Klas

2008

Volltextzugriff (PDF)

Angiogenesis: new aspects relating to its initiation and control

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 1997-01, Vol.105 (1-6), p.417-437

NORRBY, KLAS

1997

Volltextzugriff (PDF)

Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A

Acta oncologica, 2008, Vol.47 (2), p.293-300

2008

Volltextzugriff (PDF)

Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2012-02, Vol.120 (2), p.147-156

2012

Volltextzugriff (PDF)

The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin

Cancer chemotherapy and pharmacology, 2006-09, Vol.58 (3), p.354-360

2006

Volltextzugriff (PDF)

Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis

Acta oncologica, 2009, Vol.48 (3), p.418-425

2009

Volltextzugriff (PDF)

Chemotherapy and antiangiogenesis: Drug-specific, dose-related effects

Acta oncologica, 2003, Vol.42 (4), p.294-303

2003

Volltextzugriff (PDF)

Tumour-type-specific capillary endothelial cell stainability in malignant B-cell lymphomas using antibodies against CD31, CD34 and Factor VIII

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2003-04, Vol.111 (4), p.483-489

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

On Connective Tissue Mast Cells as Protectors of Life, Reproduction, and Progeny

Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?

Low-molecular-weight heparins and angiogenesis

Mast cells and angiogenesis

Do mast cells contribute to the continued survival of vertebrates?

Rat mesentery angiogenesis assay

Mast cells and angiogenesis: Review article

Human Apo-Lactoferrin Enhances Angiogenesis Mediated by Vascular Endothelial Growth Factor A in vivo

In vivo models of angiogenesis

Orally administered bovine lactoferrin systemically inhibits VEGF165-mediated angiogenesis in the rat

Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo

Basic Fibroblast Growth Factor and de Novo Maremarian Angiogenesis

Microvascular Density in Terms of Number and Length of Microvessel Segments per Unit Tissue Volume in Mammalian Angiogenesis

Drug testing with angiogenesis models

Rat Mesentery Angiogenesis Assay

In vivo angiogenesis models

2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis

Drug testing with angiogenesis models

Angiogenesis: new aspects relating to its initiation and control

Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A

Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis

The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin

Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis

Chemotherapy and antiangiogenesis: Drug-specific, dose-related effects

Tumour-type-specific capillary endothelial cell stainability in malignant B-cell lymphomas using antibodies against CD31, CD34 and Factor VIII

Suchergebnisse filtern